Contera Pharma   Report issue

For profit Phase 2
Founded: Copenhagen Denmark (2010)
Status: Acquired by Bukwang Pharmaceutical (2014)

Organization Overview

First Clinical Trial
2019
NCT03956979
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Contera Pharma